Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Woldbye, D. P. D.
Right arrow Articles by Bolwig, T. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woldbye, D. P. D.
Right arrow Articles by Bolwig, T. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Alcohol and Alcoholism Vol. 37, No. 4, pp. 318-321, 2002
© 2002 Medical Council on Alcohol

ETHANOL WITHDRAWAL IN RATS IS ATTENUATED BY INTRACEREBROVENTRICULAR ADMINISTRATION OF NEUROPEPTIDE Y

David P. D. Woldbye,*, Jakob Ulrichsen, Steven Haugbøl and Tom G. Bolwig

Laboratory of Neuropsychiatry, Department of Psychiatry, University Hospital Rigshospitalet, Department of Pharmacology, University of Copenhagen, 9 Blegdamsvej, DK-2100 Copenhagen, Denmark

Received 16 October 2001; in revised form 20 December 2001; accepted 16 January 2002

— Aims: The effects of intracerebroventricular administration of neuropeptide Y (NPY) on ethanol withdrawal were studied in rats. Methods: Ethanol was administered intragastrically five times daily for 4 days. At 16–17 h after the last infusion of ethanol, rats were rated for withdrawal using a score based on three signs: irritability, tremor and rigidity. Subsequently, the rats received an injection of NPY (12 or 24 nmol) or vehicle and were rated for signs of withdrawal. Results: At both doses, NPY significantly reduced ethanol withdrawal, the effect of the larger dose being more pronounced. Conclusions: Our results are consistent with the concept that NPY receptors are centrally involved in the regulation of neuronal excitability and might form a novel therapeutic target for treatment of ethanol withdrawal and other states of neuronal hyperexcitability.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.